Luis E Cuevas1, Roberta Petrucci, Soumya Swaminathan. 1. UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, Geneva, Switzerland. lcuevas@liv.ac.uk
Abstract
BACKGROUND: The diagnosis of childhood tuberculosis (TB) is complex and most of the new diagnostics for TB are for adults. AIMS: To review the performance of TB diagnostics and their suitability to its characteristics in young children. METHODS: Expert opinion and review of the literature. MAIN FINDINGS: The lack of a sufficient number of research studies on TB diagnostics for children hinders the preparation of systematic literature reviews. Information on test performance in children is often extrapolated from studies in adults and there is a dearth of evidence of test performance in children. Approaches to shorten the time required for diagnosis (by using a variety of specimens) are needed and there is preliminary evidence that such schemes are feasible. Diagnostics based on smear microscopy such as LED-FM, serological tests and IGRAS are unlikely to improve the diagnosis of active TB in children. Liquid and the MODS culture methods are more sensitive than solid culture, and new methods to detect mycobacterium nucleic acid or its components such as TrDNA fragments, LAMP assays and Xpert MTB/RIF have good potential to increase the number of cases confirmed. These tests should be evaluated in specimens which are easily accessible in children such as fine-needle aspiration biopsy, urine, blood and stools. INTERPRETATION: The evaluation of new diagnostic tests for TB in children is overdue. The lack of suitable diagnostic tests hinders the proper management of children, the assessment of the real burden of childhood TB, evaluation of the efficacy of new treatments and vaccines and, ultimately, the development of effective control interventions.
BACKGROUND: The diagnosis of childhood tuberculosis (TB) is complex and most of the new diagnostics for TB are for adults. AIMS: To review the performance of TB diagnostics and their suitability to its characteristics in young children. METHODS: Expert opinion and review of the literature. MAIN FINDINGS: The lack of a sufficient number of research studies on TB diagnostics for children hinders the preparation of systematic literature reviews. Information on test performance in children is often extrapolated from studies in adults and there is a dearth of evidence of test performance in children. Approaches to shorten the time required for diagnosis (by using a variety of specimens) are needed and there is preliminary evidence that such schemes are feasible. Diagnostics based on smear microscopy such as LED-FM, serological tests and IGRAS are unlikely to improve the diagnosis of active TB in children. Liquid and the MODS culture methods are more sensitive than solid culture, and new methods to detect mycobacterium nucleic acid or its components such as TrDNA fragments, LAMP assays and Xpert MTB/RIF have good potential to increase the number of cases confirmed. These tests should be evaluated in specimens which are easily accessible in children such as fine-needle aspiration biopsy, urine, blood and stools. INTERPRETATION: The evaluation of new diagnostic tests for TB in children is overdue. The lack of suitable diagnostic tests hinders the proper management of children, the assessment of the real burden of childhood TB, evaluation of the efficacy of new treatments and vaccines and, ultimately, the development of effective control interventions.
Authors: Elisabetta Walters; Marieke M van der Zalm; Anne-Marie Demers; Andrew Whitelaw; Megan Palmer; Corné Bosch; Heather R Draper; H Simon Schaaf; Pierre Goussard; Carl J Lombard; Robert P Gie; Anneke C Hesseling Journal: Pediatr Infect Dis J Date: 2019-06 Impact factor: 2.129
Authors: Suzanne T Anderson; Myrsini Kaforou; Andrew J Brent; Victoria J Wright; Lachlan J Coin; Robert S Heyderman; Michael Levin; Brian Eley; Claire M Banwell; George Chagaluka; Amelia C Crampin; Hazel M Dockrell; Neil French; Melissa S Hamilton; Martin L Hibberd; Florian Kern; Paul R Langford; Ling Ling; Rachel Mlotha; Tom H M Ottenhoff; Sandy Pienaar; Vashini Pillay; J Anthony G Scott; Hemed Twahir; Robert J Wilkinson Journal: N Engl J Med Date: 2014-05-01 Impact factor: 91.245
Authors: Eleanor S Click; Rinn Song; Jonathan P Smith; Walter Mchembere; Mark Fajans; Parisa Hariri; Elisha Okeyo; Kimberly D McCarthy; Dickson Gethi; Lazarus Odeny; Susan Musau; Albert Okumu; James Orwa; Carlos M Perez-Velez; Colleen A Wright; Mariaem Andres; Ben J Marais; H Simon Schaaf; Stephen M Graham; Andrea T Cruz; Kevin P Cain Journal: Pediatr Infect Dis J Date: 2022-07-13 Impact factor: 3.806
Authors: Philip Erik Wikman-Jorgensen; Alejandra Morales-Cartagena; Jara Llenas-García; Tomàs Maria Pérez-Porcuna; Michael Hobbins; Jochen Ehmer; Manuel Aly Mussa; Rosa Abellana; Carlos Ascaso Journal: Pathog Glob Health Date: 2015-08-04 Impact factor: 2.894
Authors: Maya Mueller-Hermelink; Robin Kobbe; Benedikt Methling; Cornelius Rau; Ulf Schulze-Sturm; Isa Auer; Frank Ahrens; Folke Brinkmann Journal: Euro Surveill Date: 2018-03